(Q36845015)

English

Tumour marker concentration at the start of chemotherapy is a stronger predictor of treatment failure than marker half-life: a study in patients with disseminated non-seminomatous testicular cancer

scientific article published on January 1997

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Tumour marker concentration at the start of chemotherapy is a stronger predictor of treatment failure than marker half-life: a study in patients with disseminated non-seminomatous testicular cancer (English)

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

author name string

de Wit R

1

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Sylvester R

2

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Tsitsa C

3

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

de Mulder PH

4

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Sleyfer DT

5

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

ten Bokkel Huinink WW

6

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Kaye SB

7

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

van Oosterom AT

8

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Boven E

9

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Vermeylen K

10

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Stoter G

11

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

language of work or name

0 references

publication date

1 January 1997

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

British Journal of Cancer

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

75

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

3

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

432-435

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Four cycles of BEP versus an alternating regime of PVB and BEP in patients with poor-prognosis metastatic testicular non-seminoma; a randomised study of the EORTC Genitourinary Tract Cancer Cooperative Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063372

29 September 2017

Long-term outcome in patients with germ cell tumours treated with POMB/ACE chemotherapy: comparison of commonly used classification systems of good and poor prognosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063372

29 September 2017

Multivariate analysis of prognostic factors in patients with disseminated nonseminomatous testicular cancer: results from a European Organization for Research on Treatment of Cancer Multiinstitutional Phase III Study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063372

27 June 2018

Prognostic factors for favorable outcome in disseminated germ cell tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063372

27 June 2018

Prognostic factors in unselected patients with nonseminomatous metastatic testicular cancer: a multicenter experience

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063372

27 June 2018

Serum tumor marker half-life during chemotherapy allows early prediction of complete response and survival in nonseminomatous germ cell tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063372

27 June 2018

The Second Medical Research Council study of prognostic factors in nonseminomatous germ cell tumors. Medical Research Council Testicular Tumour Working Party

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063372

27 June 2018

Multivariate analysis of prognostic variables in patients with metastatic testicular cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063372

5 September 2018

A prospective study of cisplatin-based combination chemotherapy in advanced germ cell malignancy: role of maintenance and long-term follow-up

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063372

5 September 2018

Phase II trial of high-dose carboplatin and etoposide with autologous bone marrow transplantation in first-line therapy for patients with poor-risk germ cell tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/9020492

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic significance of early serum tumor marker half-life in metastatic testicular teratoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/9020492

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acute changes of alpha-fetoprotein and human chorionic gonadotropin during induction chemotherapy of germ cell tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/9020492

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of criteria for assigning germ cell tumor patients to "good risk" and "poor risk" studies

1 reference

https://pubmed.ncbi.nlm.nih.gov/9020492

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic factors in advanced nonseminomatous testicular cancer. A multivariate logistic regression analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/9020492

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The management of advanced testicular teratoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/9020492

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cisplatin-based combination chemotherapy for disseminated germ cell tumors: long-term follow-up

1 reference

https://pubmed.ncbi.nlm.nih.gov/9020492

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ten-year survival and late sequelae in testicular cancer patients treated with cisplatin, vinblastine, and bleomycin

1 reference

https://pubmed.ncbi.nlm.nih.gov/9020492

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/BJC.1997.71

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36845015&oldid=2199433959"